Heiner Dreismann, Ph.D.
Roche Molecular Systems
From 2000 to 2006, Dr. Dreismann was President and CEO of Roche Molecular Systems (RMS), a division of F. Hoffmann-La Roche Ltd. and the company that pioneered molecular diagnostics in the clinical arena. During his tenure as CEO, RMS annual sales doubled to US$ 1.2 billion and the portfolio of tests and hardware sales were greatly expanded. Dr. Dreismann led the introduction of PCR-based tests in Europe as early as 1992 and witnessed firsthand the industry growth over the last two decades. Prior to being appointed CEO, Dr. Dreismann held other senior positions within Roche Diagnostics in the areas of Global Business Development, Business Unit Manager for PCR and Microbiology, as well as R&D positions in microbiology and infectious diseases, and in manufacturing. Dreismann has a Masters Degree in Biology and a PhD in Microbiology/Molecular Biology from Westfälische Wilhelms University, Muenster, Germany. He completed Post-Doctoral studies with the French Center for Nuclear Research, Sanclay, France, investigating gram-negative bacteria genetics.